{"id":11714,"date":"2008-09-10T12:53:25","date_gmt":"2008-09-10T12:53:25","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=11714"},"modified":"2026-04-02T12:51:02","modified_gmt":"2026-04-02T12:51:02","slug":"schimbari-manageriale-la-terapia-ranbaxy","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=11714","title":{"rendered":"Schimbari manageriale la Terapia Ranbaxy"},"content":{"rendered":"<p>Astfel, Ungureanu, care anterior a ocupat functia de director general al Terapia Distributie, se va ocupa de activitatile diviziilor de promovare medicala, de OTC-uri (de produse fara prescriptie medicala) si de key accounts.<\/p>\n<p>\u00a0<\/p>\n<p>&ldquo;Aceasta decizie este in concordanta cu politica companiei de concentrare si focalizare pe strategia de promovare egala a tuturor produselor si brandurilor Terapia Ranbaxy&rdquo;, a declarat <strong>Mahendra Bharadwaj<\/strong>, CEO-ul Terapia Ranbaxy.<\/p>\n<p>\u00a0<\/p>\n<p>Divizia de produse generice cu promovare medicala va fi condusa de catre <strong>Claudia Firez<\/strong>, iar cea de OTC-uri de catre <strong>Florin Neagu<\/strong>.<\/p>\n<p>\u00a0<\/p>\n<p>Terapia Ranbaxy a inregistrat, in cel de-al doilea trimestru al anului curent, vanzari de 31 de milioane de dolari (circa 13 milioane de lei), in crestere cu 5% fata de perioada similara a anului trecut, si cu 17% fata de primul trimestru, ca urmare a impactului pozitiv al prescriptiei pe brand introduse la inceputul lunii aprilie, potrivit informatiilor furnizate de reprezentantii companiei.<\/p>\n<p>\u00a0<\/p>\n<p>Piata farmaceutica a raportat, in perioada aprilie-iunie, o crestere de 21,3% fata de perioada similara a lui 2007, pana la 1,8 miliarde de lei. Primii trei mari jucatori (GlaxoSmithKline, Roche si Novartis) si-au aliniat, in intervalul iulie 2007-iunie 2008, cotele de piata, la 6,9%, iar ultimii doi au realizat vanzari egale, de 443,1 milioane de lei, potrivit datelor <strong>Cegedim<\/strong>.<br \/>\n\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Producatorul local de medicamente Terapia, parte a grupului indian Ranbaxy, a anuntat noua structura manageriala a departamentului comercial condus de Bogdan Ungureanu<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[10761,7592,7203,4895,8500],"class_list":["post-11714","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-bogdan-ungureanu","tag-farmaceutice","tag-resurse-umane","tag-schimbari","tag-terapia-ranbaxy"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/11714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11714"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/11714\/revisions"}],"predecessor-version":[{"id":32514,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/11714\/revisions\/32514"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}